Medivation Slams Sanofi's $9.3B Hostile Takeover Play
Medivation Inc. urged its shareholders Monday to resist a hostile takeover bid rival Sanofi SA launched last month after the cancer-drug maker rejected a $9.3 billion merger offer, saying to approve...To view the full article, register now.
Already a subscriber? Click here to view full article